Clinical trial

Thalidomide to Treat Oral Lesions in HIV-Infected Patients

NCT00001524

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Thalidomide Normalized identity: thalidomideView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Thalidomide to Treat Oral Lesions in HIV-Infected Patients

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1996-06-01

PhasePHASE2

Conditions

Acquired Immunodeficiency Syndromeunresolved

Burning Mouth Syndromeverified · MONDO: burning mouth syndrome

HIV Infectionverified · MONDO: HIV infectious disease

Interventions

ThalidomideDRUG · verified · RxNorm: thalidomide

Sponsors & collaborators

National Institute of Dental and Craniofacial Research (NIDCR)lead sponsor

Mapped research locations

BethesdaMaryland, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00001524 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.